Cited by 136Chronic Obstructive Pulmonary Disease (COPD) ResearchCystic Fibrosis Research AdvancesOral microbiology and periodontitis research

The DOI matches its Crossref record; 56 of the 57 references it cites were found in a registry or an index.

Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa

Open access

Millares, L., Ferrari, R., Gallego, M., Garcia-Nuñez, M., Pérez-Brocal, V., Espasa, M., Pomares, X., Monton, C., Moya, A., Monsó, E.·2014·European Journal of Clinical Microbiology & Infectious Diseases

DOI 10.1007/s10096-013-2044-0PMC PMC4042013

Open this paper in CoChat — free account Open PDF

Abstract

The bronchial microbiome in severe COPD during stability and exacerbation in patients chronically colonised by Pseudomonas aeruginosa (PA), has not been defined. Our objective was to determine the characteristics of the bronchial microbiome of severe COPD patients colonised and not colonised by P. aeruginosa and its changes during exacerbation. COPD patients with severe disease and frequent exacerbations were categorised according to chronic colonisation by P. aeruginosa. Sputum samples were obtained in stability and exacerbation, cultured, and analysed by 16S rRNA gene amplification and pyrosequencing. Sixteen patients were included, 5 of them showing chronic colonisation by P. aeruginosa. Pseudomonas genus had significantly higher relative abundance in stable colonised patients (p = 0.019), but no significant differences in biodiversity parameters were found between the two groups (Shannon, 3 (2-4) vs 3 (2-3), p = 0.699; Chao1, 124 (77-159) vs 140 (115-163), p = 0.364). In PA-colonised patients bronchial microbiome changed to a microbiome similar to non-PA-colonised patients during exacerbations. An increase in the relative abundance over 20 % during exacerbation was found for Streptococcus, Pseudomonas, Moraxella, Haemophilus, Neisseria, Achromobacter and Corynebacterium genera, which include recognised potentially pathogenic microorganisms, in 13 patients colonised and not colonised by P. aeruginosa with paired samples. These increases were not identified by culture in 5 out of 13 participants (38.5 %). Stable COPD patients with severe disease and PA-colonised showed a similar biodiversity to non-PA-colonised patients, with a higher relative abundance of Pseudomonas genus in bronchial secretions. Exacerbation in severe COPD patients showed the same microbial pattern, independently of previous colonisation by P. aeruginosa.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s10096-013-2044-0

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Fig. 1 Relative abundance of Pseudomonas genus a under stability and b during exacerbation in PA-colonised and non-PA-colonised patients. Solid line represents the mean and dashed line the medianCC BY · PubMed Central

Fig. 2 Principal coordinate analysis with Bray–Curtis dissimilarity index. a Samples from stability and b samples of exacerbation. Red dots represent colonised patients, and blue dots non-PA-colonised patientsCC BY · PubMed Central

Fig. 3 Cluster dendrogram with Bray–Curtis dissimilarity index. Samples were combined depending on their clinical situation and clustered with the Bray–Curtis index, which takes values between 0 and 1 (0 meaning that samples share all the genera and 1 meaning samples do not share any). PS colonised by P. aeruginosa under stability; PE colonised by P. aeruginosa during exacerbation; S non-colonised by P. aeruginosa under stability; E non-colonised by P. aeruginosa during exacerbation)CC BY · PubMed Central

Fig. 4 Heat map showing the most abundant genera in the four groups of samples. Columns represent the groups and rows the genera whose relative abundance is >1 % in at least one sample. The relative abundance of each genus is represented by the colour keyCC BY · PubMed Central

Fig. 5 Percentage of change in the relative abundance of genera. Only genera with a percentage of change over 20 % in at least one patient are represented. a Percentage of variability in the genera observed in consecutive samples recovered in stable situation (n = 2); b Percentage of variability in exacerbation in patients colonised by P. aeruginosa using the baseline stability sample as the reference (n = 5); c Percentage of variability in exacerbation in non-PA-colonised patients (n = 7). Dark blue: Neisseria; orange: Achromobacter; purple: Streptococcus; light blue: Pseudomonas; green: Moraxella; pink: Haemophilus; grey: CorynebacteriumCC BY · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A Mathematical Theory of Communication
Shannon, C. E. (1948) · The MIT Press eBooks · doi:10.1002/j.1538-7305.1948.tb00917.x · Cited by 50,387
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Manual of Clinical Microbiology.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-6-939_2 · Cited by 14,435
An Ordination of the Upland Forest Communities of Southern Wisconsin
Bray, J. R., & Curtis, J. T. (1957) · Ecological Monographs · doi:10.2307/1942268 · Cited by 11,736
The Mathematical Theory of Communication
Shannon, C. E., Weaver, W., & Wiener, N. (1950) · Physics Today · doi:10.1063/1.3067010 · Cited by 9,885
Standardization of Spirometry, 1994 Update. American Thoracic Society
(1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.3.7663792 · Cited by 6,605
Global Initiative for Chronic Obstructive Lung Disease
Gerald, L. B., & Bailey, W. C. (2002) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200207000-00004 · Cited by 5,806

Show all 57 references

Sorted by citations

Microbiota in health and diseases
Hou, K., Wu, Z.-X., Chen, X.-Y., Wang, J.-Q., Zhang, D., Xiao, C., Zhu, D., Koya, J. B., Wei, L., Li, J., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00974-4 · Cited by 3,171
The Microbiome and the Respiratory Tract
Dickson, R. P., Erb-Downward, J. R., Martinez, F. J., & Huffnagle, G. B. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105238 · Cited by 953
The role of the microbiome in exacerbations of chronic lung diseases
Dickson, R. P., Martinez, F. J., & Huffnagle, G. B. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61136-3 · Cited by 495
Lung microbiome dynamics in COPD exacerbations
Wang, Z., Bafadhel, M., Haldar, K., Spivak, A., Mayhew, D. N., Miller, B. E., Tal‐Singer, R., Johnston, S. L., Ramsheh, M. Y., Barer, M. R., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.01406-2015 · Cited by 469
The microbiome and critical illness
Dickson, R. P. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00427-0 · Cited by 460
Definition, Causes, Pathogenesis, and Consequences of Chronic Obstructive Pulmonary Disease Exacerbations
Ritchie, A. I., & Wedzicha, J. A. (2020) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2020.06.007 · Cited by 403
The Lung Microbiome, Immunity, and the Pathogenesis of Chronic Lung Disease
O’Dwyer, D. N., Dickson, R. P., & Moore, B. B. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600279 · Cited by 362
Acute exacerbation of COPD
Ko, F., Chan, K. P., Hui, D., Goddard, J., Shaw, J., Reid, D., & Yang, I. (2016) · Respirology (Carlton South. Print) · doi:10.1111/resp.12780 · Cited by 327
Microbiome effects on immunity, health and disease in the lung
Shukla, S. D., Budden, K. F., Neal, R., & Hansbro, P. M. (2017) · Clinical & Translational Immunology · doi:10.1038/cti.2017.6 · Cited by 287
Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations
Mayhew, D. N., Devos, N., Lambert, C., Brown, J. R., Clarke, S. C., Kim, V. L., Magid-Slav, M., Miller, B. E., Ostridge, K., Patel, R. K., et al. (2018) · Thorax · doi:10.1136/thoraxjnl-2017-210408 · Cited by 296
Interplay between the lung microbiome and lung cancer
Mao, Q., Jiang, F., Yin, R. H., Wang, J., Xia, W., Dong, G., Ma, W., Yang, Y., Xu, L., & Hu, J. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.11.036 · Cited by 253
The microbiome in respiratory medicine: current challenges and future perspectives
Faner, R., Sibila, O., Agustí, A., Bernasconi, E., Chalmers, J. D., Huffnagle, G. B., Manichanh, C., Molyneaux, P. L., Paredes, R., Pérez Brocal, V., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.02086-2016 · Cited by 247
Self-citation
Novel aspects of pathogenesis and regeneration mechanisms in COPD
Aldonytė, R., Bagdonas, E., Raudoniūtė, J., & Bružauskaitė, I. (2015) · International Journal of COPD · doi:10.2147/copd.s82518 · Cited by 229
A prospective, observational cohort study of the seasonal dynamics of airway pathogens in the aetiology of exacerbations in COPD
Wilkinson, T. M. A., Aris, E., Bourne, S. C., Clarke, S. C., Peeters, M., Pascal, T. G., Schoonbroodt, S., Tuck, A. C., Kim, V., Ostridge, K., et al. (2017) · Thorax · doi:10.1136/thoraxjnl-2016-209023 · Cited by 196
Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease
Raftery, A. L., Tsantikos, E., Harris, N. L., & Hibbs, M. L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02144 · Cited by 179
Airway host-microbiome interactions in chronic obstructive pulmonary disease
Wang, Z., Maschera, B., Lea, S., Kolsum, U., Michalovich, D., Horn, S. V., Traini, C., Brown, J. R., Hessel, E. M., & Singh, D. (2019) · Respiratory Research · doi:10.1186/s12931-019-1085-z · Cited by 159
COPD and the microbiome
Mammen, M. J., & Sethi, S. (2016) · Respirology · doi:10.1111/resp.12732 · Cited by 153
Risk factors of chronic obstructive pulmonary disease exacerbations
Hogea, P., Tudorache, E., Fildan, A. P., Firă-Mladinescu, O., Marc, M. S., & Oancea, C. I. (2019) · The Clinical Respiratory Journal · doi:10.1111/crj.13129 · Cited by 160
Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP study
Wang, Z., Singh, R., Miller, B. E., Tal‐Singer, R., Horn, S. V., Tomsho, L., Mackay, A. J., Allinson, J. P., Webb, A. J., Brookes, A. J., et al. (2017) · Thorax · doi:10.1136/thoraxjnl-2017-210741 · Cited by 147
Biomarkers of progression of chronic obstructive pulmonary disease (COPD).
Shaw, J. G., Vaughan, A., Dent, A. G., O’Hare, P. E., Goh, F., Bowman, R., Fong, K. M., & Yang, I. A. (2014) · PubMed Central · doi:10.3978/j.issn.2072-1439.2014.11.33 · Cited by 135
Natural Killer Cells in the Lungs
Cong, J., & Wei, H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01416 · Cited by 128
Bacterial-Host Interactions: Physiology and Pathophysiology of Respiratory Infection
Håkansson, A., Orihuela, C. J., & Bogaert, D. (2018) · Physiological Reviews · doi:10.1152/physrev.00040.2016 · Cited by 129
A tale of two sites: how inflammation can reshape the microbiomes of the gut and lungs
Scales, B. S., Dickson, R. P., & Huffnagle, G. B. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3mr0316-106r · Cited by 109
The Interplay Between Immune Response and Bacterial Infection in COPD: Focus Upon Non-typeable Haemophilus influenzae
Su, Y.-C., Jalalvand, F., Thegerström, J., & Riesbeck, K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02530 · Cited by 114
COPD and Gut–Lung Axis: How Microbiota and Host Inflammasome Influence COPD and Related Therapeutics
Qu, L., Cheng, Q., Wang, Y., Mu, H., & Zhang, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.868086 · Cited by 104
Characterization of the lung microbiome and exploration of potential bacterial biomarkers for lung cancer
Chen, C., Wang, Z., Wang, J., Ding, C., Sun, C., Liu, P., Xu, X., Liu, Y., Chen, B., & Gu, B. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr-19-590 · Cited by 97
Microbial burden and viral exacerbations in a longitudinal multicenter COPD cohort
Bouquet, J., Tabor, D. E., Silver, J. S., Nair, V., Tovchigrechko, A., Griffin, M. P., Esser, M. T., Sellman, B. R., & Jin, H. (2020) · Respiratory Research · doi:10.1186/s12931-020-01340-0 · Cited by 94
Lung tissue microbial profile in lung cancer is distinct from emphysema.
Liu, Y., O’Brien, J. L., Ajami, N. J., Scheurer, M. E., Amirian, E. S., Armstrong, G., Tsavachidis, S., Thrift, A. P., Jiao, L., Wong, M. C., et al. (2018) · Europe PMC (PubMed Central) · Cited by 92
Comparative analysis of the alveolar microbiome in COPD, ECOPD, Sarcoidosis, and ILD patients to identify respiratory illnesses specific microbial signatures
Gupta, S., Shariff, M., Chaturvedi, G., Sharma, A., Goel, N., Yadav, M., Mortensen, M. S., Sørensen, S. J., Mukerji, M., & Chauhan, N. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-83524-2 · Cited by 82
Understanding the role of the microbiome in chronic obstructive pulmonary disease: principles, challenges, and future directions
Huang, Y. J., Erb‐Downward, J. R., Dickson, R. P., Curtis, J. L., Huffnagle, G. B., & Han, M. K. (2016) · Translational research · doi:10.1016/j.trsl.2016.06.007 · Cited by 82
The airway microbiome in COPD, bronchiectasis and bronchiectasis‐COPD overlap
Tiew, P. Y., Jaggi, T. K., Chan, L., & Chotirmall, S. H. (2020) · The Clinical Respiratory Journal · doi:10.1111/crj.13294 · Cited by 78
Pseudomonas aeruginosa LasB Subverts Alveolar Macrophage Activity by Interfering With Bacterial Killing Through Downregulation of Innate Immune Defense, Reactive Oxygen Species Generation, and Complement Activation
Bastaert, F., Kheir, S., Saint‐Criq, V., Villeret, B., Dang, P. M., Benna, J. E., Sirard, J., Voulhoux, R., & Sallenave, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01675 · Cited by 77
The gut microbiome is a significant risk factor for future chronic lung disease
Liu, Y., Teo, S. M., Méric, G., Tang, H. H. F., Zhu, Q., Sanders, J. G., Vázquez‐Baeza, Y., Verspoor, K. M., Vartiainen, V. A., Jousilahti, P., et al. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.12.810 · Cited by 76
Microbiota dysbiosis in lung cancer: evidence of association and potential mechanisms
Xu, N., Wang, L., Li, C., Ding, C., Li, C., Fan, W., Chen, C., & Gu, B. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-156 · Cited by 71
Airway Microbiota as a Modulator of Lung Cancer
Goto, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093044 · Cited by 67
Understanding respiratory microbiome–immune system interactions in health and disease
Simone, S. K. D., Rudloff, I., Nold‐Petry, C. A., Forster, S. C., & Nold, M. F. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abq5126 · Cited by 62
The lung microbiome and exacerbations of COPD
Dy, R. V., & Sethi, S. (2016) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000268 · Cited by 62
Acute exacerbations of COPD: risk factors for failure and relapse
Mantero, M., Rogliani, P., Pasquale, M. D., Polverino, E., Crisafulli, E., Guerrero, M., Gramegna, A., Cazzola, M., & Blasi, F. (2017) · International Journal of COPD · doi:10.2147/copd.s145253 · Cited by 61
Understanding Persistent Bacterial Lung Infections
Pragman, A. A., Berger, J. P., & Williams, B. J. (2016) · Clinical Pulmonary Medicine · doi:10.1097/cpm.0000000000000108 · Cited by 60
Relationship between the respiratory microbiome and the severity of airflow limitation, history of exacerbations and circulating eosinophils in COPD patients
Millares, L., Pascual-Guàrdia, S., Montón, C., García-Núñez, M., Lalmolda, C., Faner, R., Casadevall, C., Setó, L., Capilla, S., Moreno, A., et al. (2019) · BMC Pulmonary Medicine · doi:10.1186/s12890-019-0867-x · Cited by 61
Self-citation
Influence of Hypoxia on the Epithelial-Pathogen Interactions in the Lung: Implications for Respiratory Disease
Page, L. K., Staples, K. J., Spalluto, C. M., Watson, A., & Wilkinson, T. M. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.653969 · Cited by 59
The bacterial microbiota in inflammatory lung diseases
Huffnagle, G. B., & Dickson, R. P. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.05.022 · Cited by 55
Nontypeable Haemophilus influenzae and chronic obstructive pulmonary disease: a review for clinicians
Sriram, K. B., Cox, A. J., Clancy, R. L., Slack, M., & Cripps, A. W. (2017) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2017.1329274 · Cited by 58
Non-typeable Haemophilus influenzae protein vaccine in adults with COPD: A phase 2 clinical trial
Wilkinson, T. M. A., Schembri, S., Brightling, C. E., Bakerly, N. D., Lewis, K. E., MacNee, W., Rombo, L., Hedner, J. A., Allen, M. B., Walker, P. P., et al. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.07.100 · Cited by 56
The lung microbiome dynamics between stability and exacerbation in chronic obstructive pulmonary disease (COPD): Current perspectives
Dima, E., Kyriakoudi, A., Kaponi, M., Vasileiadis, I., Stamou, P., Koutsoukou, A., Koulouris, N. G., & Rovina, N. (2019) · Respiratory Medicine · doi:10.1016/j.rmed.2019.08.012 · Cited by 53
Treatment of patients with COPD and recurrent exacerbations: the role of infection and inflammation
Santos, S., Marín, A., Serra-Batllés, J., de la Rosa, D., Solanes, I., Pomares, X., López‐Sánchez, M., Muñoz‐Esquerre, M., & Miravitlles, M. (2016) · International Journal of COPD · doi:10.2147/copd.s98333 · Cited by 49
Self-citation
Role of infection in exacerbations of chronic obstructive pulmonary disease
Miravitlles, M., & Anzueto, A. (2015) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000154 · Cited by 49
Gut microbiome and response to checkpoint inhibitors in non-small cell lung cancer—A review
Nagasaka, M., Sexton, R. E., Alhasan, R., Rahman, S. B., Azmi, A. S., & Sukari, A. W. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.102841 · Cited by 51
Functional Metagenomics of the Bronchial Microbiome in COPD
Millares, L., Pérez‐Brocal, V., Ferrari, R. G., Gallego, M., Pomares, X., García-Núñez, M., Montón, C., Capilla, S., Monsó, E., & Moyá, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144448 · Cited by 48
Self-citation
Pseudomonas aeruginosastimulates nuclear sphingosine-1-phosphate generation and epigenetic regulation of lung inflammatory injury
Ebenezer, D. L., Berdyshev, E. V., Bronova, I. A., Liu, Y., Tiruppathì, C., Komarova, Y. A., Benevolenskaya, E. V., Suryadevara, V., Ha, A. W., Harijith, A. K., et al. (2019) · Thorax · doi:10.1136/thoraxjnl-2018-212378 · Cited by 47
Genetic mannose binding lectin deficiency is associated with airway microbiota diversity and reduced exacerbation frequency in COPD
Dicker, A., Crichton, M. L., Cassidy, A., Brady, G., Hapca, A., Tavendale, R., Einarsson, G. G., Furrie, E., Elborn, J. S., Schembri, S., et al. (2017) · Thorax · doi:10.1136/thoraxjnl-2016-209931 · Cited by 40
The Human Respiratory Microbiome: Implications and Impact
Mitchell, A. B., & Glanville, A. R. (2018) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0037-1617441 · Cited by 38
Bacterial–viral load and the immune response in stable and exacerbated COPD: significance and therapeutic prospects
D’Anna, S. E., Balbi, B., Cappello, F., Carone, M., & Stefano, A. D. (2016) · International Journal of COPD · doi:10.2147/copd.s93398 · Cited by 38
Microbiome in chronic obstructive pulmonary disease
Monsó, E. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.04.20 · Cited by 39
Self-citation
Accelerated Lung Function Decline and Mucus–Microbe Evolution in Chronic Obstructive Pulmonary Disease
Meldrum, O. W., Donaldson, G. C., Narayana, J. K., Ivan, F. X., Jaggi, T. K., Aogáin, M. M., Finney, L., Allinson, J. P., Wedzicha, J. A., & Chotirmall, S. H. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202306-1060oc · Cited by 39
Impact of micro‐environmental changes on respiratory tract infections with intracellular bacteria
Shima, K., Coopmeiners, J., Graspeuntner, S., Dalhoff, K., & Rupp, J. (2016) · FEBS Letters · doi:10.1002/1873-3468.12353 · Cited by 36
Influence of the Lung Microbiota Dysbiosis in Chronic Obstructive Pulmonary Disease Exacerbations: The Controversial Use of Corticosteroid and Antibiotic Treatments and the Role of Eosinophils as a Disease Marker
Toraldo, D. M., & Conte, L. (2019) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3875 · Cited by 36
Bronchial Microbiome, PA Biofilm-Forming Capacity and Exacerbation in Severe COPD Patients Colonized by P. Aeruginosa
García-Núñez, M., Martí, S., Puig, C., Pérez‐Brocal, V., Millares, L., Santos, S., Ardanuy, C., Moyá, A., Liñares, J., & Monsó, E. (2017) · Future Microbiology · doi:10.2217/fmb-2016-0127 · Cited by 37
Self-citation
The Influence of the Gut Microbiota on Host Health: A Focus on the Gut–Lung Axis and Therapeutic Approaches
Alswat, A. S. (2024) · Life · doi:10.3390/life14101279 · Cited by 38
C-reactive protein in outpatients with acute exacerbation of COPD: its relationship with microbial etiology and severity
Gallego, M., Pomares, X., Capilla, S., Marcos, M. Á., Suarez, D. L., Monsó, E., & Montón, C. (2016) · International Journal of COPD · doi:10.2147/copd.s117129 · Cited by 34
Self-citation
The Microbiome in COPD: Emerging Potential for Microbiome-Targeted Interventions
Millares, L., & Monsó, E. (2022) · International Journal of COPD · doi:10.2147/copd.s371958 · Cited by 32
Self-citation
The Sputum Microbiome in Chronic Obstructive Pulmonary Disease Exacerbations
Huang, Y. J., & Boushey, H. A. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201506-319aw · Cited by 31
Pseudomonas aeruginosa Protease IV Exacerbates Pneumococcal Pneumonia and Systemic Disease
Bradshaw, J. L., Caballero, A. R., Bierdeman, M. A., Adams, K. V., Pipkins, H. R., Tang, A., O’Callaghan, R. J., & McDaniel, L. S. (2018) · mSphere · doi:10.1128/msphere.00212-18 · Cited by 30
How bacteria hack the matrix and dodge the bullets of immunity
Paulsson, M., & Riesbeck, K. (2018) · European Respiratory Review · doi:10.1183/16000617.0018-2018 · Cited by 29
Real-time PCR has advantages over culture-based methods in identifying major airway bacterial pathogens in chronic obstructive pulmonary disease: Results from three clinical studies in Europe and North America
Schoonbroodt, S., Ichanté, J.-L., Boffé, S., Devos, N., Devaster, J., Taddei, L., Rondini, S., Arora, A. K., Pascal, T. G., & Malvaux, L. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1098133 · Cited by 28
The respiratory microbiome in bronchial mucosa and secretions from severe IgE-mediated asthma patients
Millares, L., Bermudo, G., Pérez‐Brocal, V., Domingo, C., García-Núñez, M., Pomares, X., Moyá, A., & Monsó, E. (2017) · BMC Microbiology · doi:10.1186/s12866-017-0933-6 · Cited by 27
Self-citation
Symptom-related sputum microbiota in stable chronic obstructive pulmonary disease
Diao, W., Shen, N., Du, Y., Erb‐Downward, J. R., Sun, X., Guo, C., Qian, K., Huffnagle, G. B., Gyetko, M. R., & He, B. (2018) · International Journal of COPD · doi:10.2147/copd.s167618 · Cited by 25
Predicting BPD: Lessons Learned From the Airway Microbiome of Preterm Infants
Gentle, S. J., & Lal, C. V. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00564 · Cited by 26
A narrative review from gut to lungs: non-small cell lung cancer and the gastrointestinal microbiome
Shah, H., & Ng, T. L. (2023) · Translational Lung Cancer Research · doi:10.21037/tlcr-22-595 · Cited by 24
The pulmonary microbiome: challenges of a new paradigm
Costa, A. N., da Costa, F. M., Campos, S. V., Salles, R. K., & Athanazio, R. A. (2018) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37562017000000209 · Cited by 29
Drivers of year-to-year variation in exacerbation frequency of COPD: analysis of the AERIS cohort
Wilkinson, T. M. A., Aris, E., Bourne, S. C., Clarke, S. C., Peeters, M., Pascal, T. G., Taddei, L., Tuck, A. C., Kim, V. L., Ostridge, K., et al. (2019) · ERJ Open Research · doi:10.1183/23120541.00248-2018 · Cited by 24
JTD special edition 'Hot Topics in COPD'-The microbiome in COPD.
Chambers, D. C., Gellatly, S. L., Hugenholtz, P., & Hansbro, P. M. (2014) · PubMed Central · doi:10.3978/j.issn.2072-1439.2014.11.08 · Cited by 22
Greater eosinophil counts at first COPD hospitalization are associated with more readmissions and fewer deaths
Li, Q., Larivée, P., Courteau, J., Couillard, S., Poder, T. G., Carrier, N., Bélanger, M., & Vanasse, A. (2019) · International Journal of COPD · doi:10.2147/copd.s187375 · Cited by 22
Disruptions in oral and nasal microbiota in biomass and tobacco smoke associated chronic obstructive pulmonary disease
Agarwal, D. M., Dhotre, D. P., Kumbhare, S. V., Gaike, A. H., Brashier, B. B., Shouche, Y. S., Juvekar, S. K., & Salvi, S. (2021) · Archives of Microbiology · doi:10.1007/s00203-020-02155-9 · Cited by 22
A Systematic Review and Meta-Analysis of the Prevalence and Impact of Pulmonary Bacterial Colonisation in Stable State Chronic Obstructive Pulmonary Disease (COPD)
Armitage, M. N., Spittle, D. A., & Turner, A. M. (2021) · Biomedicines · doi:10.3390/biomedicines10010081 · Cited by 21
Microbial diversity and antimicrobial susceptibility in endotracheal tube biofilms recovered from mechanically ventilated COVID-19 patients
van Charante, F., Wieme, A. D., Rigole, P., Canck, E. D., Ostyn, L., Grassi, L. C., Deforce, D. L. D., Crabbé, A., Vandamme, P. A. R., Joossens, M., et al. (2022) · Biofilm · doi:10.1016/j.bioflm.2022.100079 · Cited by 21
Altered community compositions of Proteobacteria in adults with bronchiectasis
Guan, W., Yuan, J.-J., Li, H., Gao, Y., Chen, C.-L., Huang, Y., Chen, R., & Zhong, N. (2018) · International Journal of COPD · doi:10.2147/copd.s159335 · Cited by 20
Lung Microbiome in Human Health and Diseases
Chauhan, N. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00077-2 · Cited by 20
The impact of infection with COVID-19 on the respiratory microbiome: A narrative review
Zhu, T., Jin, J. J., Chen, M., & Chen, Y. (2022) · Virulence · doi:10.1080/21505594.2022.2090071 · Cited by 20
Mirar el bosque y no el árbol: el microbioma en la enfermedad pulmonar obstructiva crónica y la fibrosis quística
Monsó, E. (2019) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2019.04.017 · Cited by 19
Self-citation
Impact of Radiographic Bronchiectasis in COPD
Shi, L., Wei, F., Tiantian, M., Zhou, W., Li, M., & Wan, Y. (2020) · Respiratory Care · doi:10.4187/respcare.07390 · Cited by 19
Look at the wood and not at the tree: The microbiome in chronic obstructive lung disease and cystic fibrosis
Monsó, E. (2019) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2019.04.014 · Cited by 18
Self-citation
Alteration of the Respiratory Microbiome in Hospitalized Patients with Asthma–COPD Overlap during and after an Exacerbation
Alsayed, A. R., Abed, A. I., Jarrar, Y. B., Alshammari, F., Alshammari, B., Basheti, I. A., & Zihlif, M. A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12062118 · Cited by 17
The association between the respiratory tract microbiome and clinical outcomes in patients with COPD
Yu, S., Zhang, H., Wan, L., Xue, M. F., Zhang, Y., & Gao, X. (2022) · Microbiological Research · doi:10.1016/j.micres.2022.127244 · Cited by 18
Reliable detection of Host-Microbe Signatures in cancer using PRISM
Ghaddar, B., Blaser, M. J., & De, S. (2026) · Cancer Cell · doi:10.1016/j.ccell.2026.01.007 · Cited by 18
Short term dynamics of the sputum microbiome among COPD patients
Sinha, R., Weissenburger-Moser, L. A., Clarke, J., Smith, L. M., Heires, A. J., Romberger, D. J., & LeVan, T. D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191499 · Cited by 17
Associated Factors of Pneumonia in Individuals with Chronic Obstructive Pulmonary Disease (COPD) Apart from the Use of Inhaled Corticosteroids
Lineros, R., Fernández-Delgado, L., Vega, A. P., Chacón, P., Doukkali, B., Monteseirı́n, J., & Perez, D. R. (2023) · Biomedicines · doi:10.3390/biomedicines11051243 · Cited by 18
Real-world antibiotic use in treating acute exacerbations of chronic obstructive pulmonary disease (AECOPD) in China: Evidence from the ACURE study
Ma, Y., Huang, K., Liang, C., Mao, X., Zhang, Y., Zhan, Z., Yang, T., & Chen, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.649884 · Cited by 13
Effects of Fluticasone Propionate on Klebsiella pneumoniae and Gram-Negative Bacteria Associated with Chronic Airway Disease
Begley, L., Opron, K., Bian, G., Kozik, A. J., Liu, C., Felton, J. A., Wen, B., Sun, D., & Huang, Y. J. (2022) · mSphere · doi:10.1128/msphere.00377-22 · Cited by 12
Exploring the Role of Gut-Lung Interactions in COPD Pathogenesis: A Comprehensive Review on Microbiota Characteristics and Inflammation Modulation
Cheng, Z.-X., & Zhang, J. (2024) · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · doi:10.15326/jcopdf.2023.0442 · Cited by 15
Targeting respiratory microbiomes in COPD and bronchiectasis
Aogáin, M. M., Tiew, P. Y., Jaggi, T. K., Narayana, J. K., Singh, S., Hansbro, P. M., Segal, L. N., & Chotirmall, S. H. (2024) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2024.2355155 · Cited by 11
Gut–Lung Microbiota Interaction in COPD Patients: A Literature Review
Krūmiņa, A., Bogdanova, M., Gintere, S., & Vīksna, L. (2022) · Medicina · doi:10.3390/medicina58121760 · Cited by 12
Commensal Microbes Affect Host Humoral Immunity to Bordetella pertussis Infection
Zhang, Y., Ran, Z., Tian, M., Zhou, Y., Yang, J., Yin, J. J., Lu, D., Li, R. Q., & Zhong, J. S. (2019) · Infection and Immunity · doi:10.1128/iai.00421-19 · Cited by 10
Antibacterial Activity of Herbal Plantago major and Plantago lanceolata extracts on Pseudomonas aeruginosa with emphasis on Exotoxin A gene expression and Bioinformatics approachPreprint
ABBASI, A., Maddah, S. M., Ali, D. S., & Kamalinejad, M. (2022) · Research Square · doi:10.21203/rs.3.rs-1637465/v1 · Cited by 9
A succession of pulmonary microbiota in broilers during the growth cycle
Shen, D., Wang, K., Fathi, M. A., Li, Y., Win‐Shwe, T., & Li, C. (2023) · Poultry Science · doi:10.1016/j.psj.2023.102884 · Cited by 8
The battle within: how Pseudomonas aeruginosa uses host-pathogen interactions to infect the human lung
Vaz, C. M., Mülberger, A. G., & Torrent, M. (2024) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2024.2407378 · Cited by 8
Glucocorticoids and antibiotics, how do they get together?
Reidl, J., & Monsó, E. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201505336 · Cited by 8
Self-citation
New insights into the pathophysiology and epidemiology of COPD exacerbations
Finney, L., MacLeod, M. A., & Wedzicha, J. A. (2024) · European Respiratory Society eBooks · doi:10.1183/2312508x.10007923 · Cited by 7
Global Research Trends on the Link Between the Microbiome and COPD: A Bibliometric Analysis
Chen, D., Zeng, Q., Liu, L., Zhou, Z., Qi, W., Yu, S., & Zhao, L. (2023) · International Journal of COPD · doi:10.2147/copd.s405310 · Cited by 9
Potential of Health and Demographic Surveillance System in Asthma and Chronic Obstructive Pulmonary Disease Microbiome Research
Agarwal, D. M., Dhotre, D. P., Patil, R., Shouche, Y. S., Juvekar, S. K., & Salvi, S. (2017) · Frontiers in Public Health · doi:10.3389/fpubh.2017.00196 · Cited by 7

Authors: Millares, L., Ferrari, R., Gallego, M., Garcia-Nuñez, M., Pérez-Brocal, V., Espasa, M., Pomares, X., Monton, C., Moya, A., & Monsó, E.
Affiliations: Universitat de València (ES)
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES)
Corporació Sanitària Parc Taulí (ES)
Universitat Autònoma de Barcelona (ES)
Corresponding author: Monsó, E.
ORCID: Millares, L.
Ferrari, R.
Gallego, M.
Espasa, M.
Pomares, X.
Venue: European Journal of Clinical Microbiology & Infectious Diseases
Publisher: Springer Science and Business Media LLC
Published: 2014-01-22
Volume: 33
Issue: 7
Pages: 1101-1111
ISSN: 0934-9723 (ISSN-L)
1435-4373
DOI: 10.1007/s10096-013-2044-0
PMC: PMC4042013
OpenAlex: W2069385595
Cited by: 136
References: 57
Citations by year: 2026: 3 · 2025: 4 · 2024: 14 · 2023: 8 · 2022: 16 · 2021: 9 · 2020: 12 · 2019: 14 · 2018: 15 · 2017: 16 · 2016: 13 · 2015: 8 · 2014: 4
FWCI: 10.94
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
creativecommons.org/licenses/by/2.0 (unspecified)
Locations: European Journal of Clinical Microbiology & Infectious Diseases (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
Funders: Ministerio de Economía y Competitividad (SAF2012, SAF 2012-31187)
Generalitat Valenciana (Prometeo/2009/092)
Sociedad Española de Neumología y Cirugía Torácica
Instituto de Salud Carlos III (Marató de TV3)
Topics: Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
Keywords: chronic obstructive pulmonary disease, COPD exacerbations, sputum microbiota, bacterial diversity, potentially pathogenic microorganisms, Streptococcus, Moraxella, Haemophilus, Neisseria, Corynebacterium, Achromobacter
MeSH terms: Aged, Aged, 80 and over, Bronchi, DNA, Bacterial, DNA, Ribosomal, Female, Humans, Male, Middle Aged, Molecular Sequence Data, Phylogeny, RNA, Ribosomal, 16S, Sputum, Cohort Studies, Cluster Analysis, Sequence Analysis, DNA, Pulmonary Disease, Chronic Obstructive, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks